These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 14638353

  • 1. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.
    Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S.
    Am J Gastroenterol; 2003 Nov; 98(11):2485-90. PubMed ID: 14638353
    [Abstract] [Full Text] [Related]

  • 2. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis.
    Dufour JF, Oneta CM, Gonvers JJ, Bihl F, Cerny A, Cereda JM, Zala JF, Helbling B, Steuerwald M, Zimmermann A, Swiss Association for the Study of the Liver.
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1537-43. PubMed ID: 17162245
    [Abstract] [Full Text] [Related]

  • 3. The role of vitamin E and C therapy in NASH.
    Harrison SA, Ward JA, Schenker S.
    Am J Gastroenterol; 2004 Sep; 99(9):1862. PubMed ID: 15330932
    [No Abstract] [Full Text] [Related]

  • 4. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
    Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, David E, Rizzetto M, Marchesini G.
    Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
    [Abstract] [Full Text] [Related]

  • 5. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.
    Zelber-Sagi S, Kessler A, Brazowsky E, Webb M, Lurie Y, Santo M, Leshno M, Blendis L, Halpern Z, Oren R.
    Clin Gastroenterol Hepatol; 2006 May; 4(5):639-44. PubMed ID: 16630771
    [Abstract] [Full Text] [Related]

  • 6. A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial.
    Nelson A, Torres DM, Morgan AE, Fincke C, Harrison SA.
    J Clin Gastroenterol; 2009 May; 43(10):990-4. PubMed ID: 19448566
    [Abstract] [Full Text] [Related]

  • 7. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
    Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA.
    Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
    [Abstract] [Full Text] [Related]

  • 8. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
    Huang MA, Greenson JK, Chao C, Anderson L, Peterman D, Jacobson J, Emick D, Lok AS, Conjeevaram HS.
    Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia.
    Hyogo H, Tazuma S, Arihiro K, Iwamoto K, Nabeshima Y, Inoue M, Ishitobi T, Nonaka M, Chayama K.
    Metabolism; 2008 Dec; 57(12):1711-8. PubMed ID: 19013295
    [Abstract] [Full Text] [Related]

  • 10. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis.
    Aithal GP, Thomas JA, Kaye PV, Lawson A, Ryder SD, Spendlove I, Austin AS, Freeman JG, Morgan L, Webber J.
    Gastroenterology; 2008 Oct; 135(4):1176-84. PubMed ID: 18718471
    [Abstract] [Full Text] [Related]

  • 11. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.
    Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, Lymp JF, Burgart L, Colin P.
    Hepatology; 2004 Mar; 39(3):770-8. PubMed ID: 14999696
    [Abstract] [Full Text] [Related]

  • 12. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.
    Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ.
    Hepatology; 2003 Aug; 38(2):413-9. PubMed ID: 12883485
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.
    Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR.
    Hepatology; 2003 Oct; 38(4):1008-17. PubMed ID: 14512888
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [Abstract] [Full Text] [Related]

  • 17. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
    Harrison SA, Torgerson S, Hayashi PH.
    Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
    [Abstract] [Full Text] [Related]

  • 18. Impact of vitamin E and C supplementation on serum adhesion molecules in chronic degenerative aortic stenosis: a randomized controlled trial.
    Tahir M, Foley B, Pate G, Crean P, Moore D, McCarroll N, Walsh M.
    Am Heart J; 2005 Aug; 150(2):302-6. PubMed ID: 16086935
    [Abstract] [Full Text] [Related]

  • 19. Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer.
    Gothard L, Cornes P, Earl J, Hall E, MacLaren J, Mortimer P, Peacock J, Peckitt C, Woods M, Yarnold J.
    Radiother Oncol; 2004 Nov; 73(2):133-9. PubMed ID: 15542159
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.